Qianjiang Biochemical released its 2026 interim report. During the reporting period, the company's total operating revenue was 733 million yuan, a decrease of 46.4176 million yuan compared with the same period last year, down 5.95% year-on-year. Net profit attributable to the parent company was 77.7648 million yuan, a decrease of 29.3552 million yuan compared with the same period last year, down 27.40% year-on-year. Net cash inflow from operating activities was 5.2746 million yuan, a sharp year-on-year decline of 95.02%. The company's asset-liability ratio was 49.88%, and its gross margin was 27.86%, achieving six consecutive years of growth. ROE was 2.23%, and diluted earnings per share was 0.09 yuan. The number of shareholders was 25,200, and the top ten shareholders held 76.87% of the total share capital.
Zhejiang Qianjiang Biochemical Co LtdNet profit fell 27.40% year-on-year and operating cash flow plunged 95.02%.
